When San Diego’s Epic Sciences raised $30 million almost three years ago, CEO Murali Prahalad told me he saw a big opportunity to use the company’s technology as a diagnostic test to assess how well a cancer patient is responding to... Read more »
Ann Arbor, MI-based Renaissance Venture Capital Fund announced this week that it has invested in Austin, TX-based Next Coast Ventures. The fund-of-funds, which puts money into out-of-state VC funds to help entice them to invest in Michigan startups, did not... Read more »
SmartUQ, a Madison, WI-based software developer whose digital tools allow users to test the performance of physical products and the parts they’re made of, has raised more than $1.9 million from investors.
Twenty-five investors participated in the equity financing round,... Read more »
Amazon, the behemoth of digital and physical commerce, started out as an independent bookseller, albeit an online one, based in a home in Bellevue, WA. Now that it’s doing everything else—this week it deployed artificial intelligence to judge your fashion choices... Read more »
TCC Software Solutions, an Indianapolis-based IT cloud-hosting company, announced this week that it has acquired two businesses: Vertex Solutions Group and Triple Impact. Financial terms of the deal were not disclosed.
Jim Pangallo, principal partner at TCC, says the two... Read more »
BioMarin Pharmaceuticals has won the first FDA approval for a treatment for Batten disease, a rare group of disorders that rob children of vision, cognitive abilities, and motor skills, and usually prove deadly before adulthood.
Richardson, TX—The University of Texas at Dallas today formally kicks off its Blackstone LaunchPad program, one of three cross-disciplinary entrepreneurship centers opening at universities across the state.
The program, funded by a $1 million donation from the charitable arm of... Read more »
Two of the most noteworthy drugs to win FDA approval over the past year, eteplirsen (Exondys 51) and nusinersen (Spinraza), have something important in common: Patient groups have played a critical role in both of their stories.
Eteplirsen, Sarepta Therapeutics’ (NASDAQ:... Read more »
Earlier this month, the Michigan State University-backed Conquer accelerator program announced the five startups that will spend the summer pushing their products and technologies to market.
Starting in June, Conquer participants will begin the 10-week incubation program. What makes Conquer different... Read more »
[Corrected 4/27/17, 11:57 p.m. See Below.] Arsanis, a Waltham, MA-based biotech co-founded by scientist and entrepreneur Tillman Gerngross to develop treatments for bacterial and viral infections, has raised a $45.5 million investment led by the Bill & Melinda Gates Foundation... Read more »
Catch up on news from Wisconsin’s innovation community, starting with these recent headlines:
The Indianapolis-based startup Greenlight.guru, maker of quality management software for organizations in the medical device industry, plans to invest $651,022 in a new, 7,200-square-foot office at Union 525, a tech hub in the city’s downtown. The new office is... Read more »
One reason that drug-resistant “superbugs” are a growing healthcare problem is the hardiness of gram-negative bacteria, a type of bacteria whose characteristics render many antibiotics ineffective. Forge Therapeutics says it has found a way to target an enzyme found only in... Read more »
Cellular Dynamics International, a Madison, WI-based manufacturer of human cells, recently signed a collaboration agreement with the Harvard Stem Cell Institute that’s aimed at making greater quantities of stem cells available to researchers at the institute and its affiliates.
CDI... Read more »
VP of Research & Policy, Ewing Marion Kauffman Foundation
President and CEO, Lumina Foundation
CEO of Zero Locus
VP of Research and Special Initiatives, Google
Head of global research and development at Life Technologies